STAT+: FDA expands Bayer lung cancer drug approval
UniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout
Lees bij STAT News · 10 september 2026 om 13:36
STAT+: FDA expands Bayer lung cancer drug approval
Alle berichten over deze gebeurtenis, automatisch gegroepeerd uit meerdere onafhankelijke bronnen.
Laatst bijgewerkt: 10 september 2026 om 14:47 · 5 artikelen · 1 bronnen
STAT+: Cancer medicines remain in short supply across the U.S., survey finds
An ongoing shortage of cancer medications continues to force leading cancer centers around the U.S. to seek work-around strategies to treat patients and a majority also report that clinical trials…
Lees bij STAT News · 10 september 2026 om 13:01
STAT+: What to expect from UniQure’s upcoming Huntington’s gene therapy readout
Before the end of September, UniQure is expected to report four-year results from the closely tracked clinical trial of its gene therapy for Huntington’s disease.
Lees bij STAT News · 10 september 2026 om 10:30
STAT+: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon
A Roivant lung disease drug has succeeded in a mid-stage study. But the drug’s origins are another fascinating aspect to the story.
Lees bij STAT News · 10 september 2026 om 10:30
STAT+: Five midterm races to watch that could be crucial for vaccine policy
GOP candidates in Iowa and Florida are embracing vaccine skepticism, while Democrats in Michigan and South Carolina are ready for a fight.
Lees bij STAT News · 10 september 2026 om 08:30